The present study aims to examine whether febuxostat prevents a further reduction in renal function as assessed with eGFR in subjects and will ( 1 ) provide evidence to indicate the inverse association between a reduction in SUA concentration and an improvement in renal function and ( 2 ) rationalize pharmacotherapy for subjects and clarify its clinical relevance .